DOJ Drops Probe into Abbott Laboratories Baby Formula Plant

The U.S. Department of Justice (DOJ) has closed its investigation into Abbott Laboratories' (ABT) baby formula plant without filing charges, according to sources familiar with the matter. The decision ends a multi-year probe into potential contamination risks at the facility.

Details of the Action

The investigation stemmed from reports of quality issues at Abbott's Sturgis, Michigan plant, which had been subject to prior product recalls. The DOJ conducted a thorough review of documents and processes but ultimately decided not to pursue the case.

Company's Stance

Abbott Laboratories affirmed its commitment to product safety and quality, welcoming the DOJ's decision. The company stated it fully cooperated with the investigation and has made significant improvements to its manufacturing processes.

Precedents and Context

In 2022, Abbott recalled several baby formula products following reports of bacterial infections, leading to a nationwide shortage. Since then, the company has invested in upgrading its plant and enhancing safety protocols.

Potential Financial Impact

The closure of the investigation is expected to remove a layer of legal and regulatory uncertainty that had weighed on the stock. However, the company still faces private lawsuits related to the same incident.